Hematologist Oncologist - H-1B Visa Sponsors

7 employers filed 18 LCA applications for Hematologist Oncologist positions.

đź“Ť Employers Hiring for This Role

Click an employer to view their full sponsorship profile.

Hematologist Oncologist7 total
BARBARA ANN KARMANOS CANCER INSTITUTE
DETROIT, MI7 filings
BAYSTATE MEDICAL PRACTICES, INC
SPRINGFIELD, MA4 filings
COVENANT MEDICAL CENTER, INC
WATERLOO, IA2 filings
NORTHERN VIRGINIA HEMATOLOGY ONCOLOGY ASSOCIATES, INC
WOODBRIDGE, VA2 filings
OCHSNER CLINIC FOUNDATION
NEW ORLEANS, LA1 filings
WILLIS-KNIGHTON MEDICAL CENTER, INC
SHREVEPORT, LA1 filings
BAPTIST HEALTH SOUTH FLORIDA, INC
CORAL GABLES, FL1 filings

Work Visa Categories

H-1B
Most common US work visa for specialty occupations
Annual cap:65,000 + 20,000 (US master’s)
Lottery:Yes, weighted by wage level from FY2027
Duration:3 years, extendable to 6
Spouse work:H-4 EAD if I-140 approved
H-1B Cap-Exempt
No lottery required. Qualifying employers only
Annual cap:None. File any time
Lottery:None. No registration needed
Who qualifies:Nonprofit universities, research orgs, affiliates
Duration:Same as regular H-1B
E-3
Australian nationals only. Cap rarely reached
Annual cap:10,500. Never exhausted
Lottery:None
Duration:2 years, renewable indefinitely
Spouse work:E-3D automatic work authorization
H-1B1
Chile & Singapore nationals. Free Trade Agreement
Annual cap:6,800 (1,400 Chile + 5,400 Singapore)
Lottery:None
Duration:1 year, renewable
Spouse work:No automatic work authorization

H-1B Wage Levels Explained

LEVEL I · ENTRY
“Performs routine tasks requiring limited, if any, exercise of judgment. Work is closely supervised.”
In practice:Work is assigned and checked by a supervisor. The employee is learning the employer’s methods. Mistakes are caught and corrected by others.
Associate EngineerJunior AnalystNew Graduate
1Ă—lottery entry under FY2027 weighted system
If your LCA description lists “5+ years of experience,” “works independently,” or “leads a team”, Level I may be inconsistent with those duties and could attract RFE scrutiny.